Continuation of Immunomodulators in IBD Patients Starting Anti-TNFs Evaluated in Meta-Analysis

Crohn's Disease Forum

Help Support Crohn's Disease Forum:

Joined
Mar 17, 2013
Messages
1,337
http://www.gastroendonews.com/ViewA...News&d_id=187&i=May+2014&i_id=1059&a_id=27435

The benefit of keeping patients with Crohn’s disease on an immunomodulator after starting an anti-tumor necrosis factor (TNF) agent appears to differ based on the specific anti-TNF agent used....Outcomes were improved when immunomodulator therapy was continued in patients initiating infliximab but not in those initiating adalimumab or certolizumab.
 
Back
Top